Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jan 2018

Bauer L, Hapfelmeier A, Blank S, Reiche M, Slotta-Huspenina J, Jesinghaus M, Novotny A, Schmidt T, Grosser B, Kohlruss M, Weichert W, Ott K, Keller G

Abstract excerpt

Background: Perioperative chemotherapy is an established treatment of advanced gastric cancer patients. Treatment selection is based on clinical staging (cT). We aimed to establish and validate a prognostic score including clinical and molecular factors, to optimize treatment decisions for these patients. Patients and methods: We analyzed 626 carcinomas of the stomach and of the gastro-esophageal junction from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to CCL5 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CTNNB1 gene

Share to Gene Expression Profiling

Share to Genetic Predisposition to Disease

Share to Prognosis

Share to Stomach Neoplasms

Source

Identifiers

PMID: 29069277
DOI: 10.1093/annonc/mdx685

Genes

CCL5
CTNNB1
EXOSC3
LZTR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.PMID 29069277Read ↗

A gene expression-based risk model reveals prognosis of gastric cancerSemantic proximity Read ↗

A novel gene expression-based prognostic scoring system to predict survival in gastric cancerSemantic proximity Read ↗

Identification of 10 Gene Signatures as Prognostic Biomarkers for Peritoneal Metastatic Gastric CancerSemantic proximity Read ↗

Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric CancerSemantic proximity Read ↗

Efferocytosis-Related LncRNA Signatures for Predicting Prognosis and Immune Landscape of Gastric CancerSemantic proximity Read ↗

Transcriptomic Profiling of Gastric Cancer Reveals Key Biomarkers and Pathways via Bioinformatic AnalysisSemantic proximity Read ↗

A three‐lncRNA expression signature associated with the prognosis of gastric cancer patientsSemantic proximity Read ↗

Prognosis and Immune Correlation Analysis of m1A/m5C/m6A/m7G Regulated Genes in Gastric CancerSemantic proximity Read ↗

Integrin-based prognostic model predicts survival, immunotherapy response, and drug sensitivity in gastric cancerSemantic proximity Read ↗

Development and validation of an immune-related gene-based prognostic signature in gastric cancerSemantic proximity Read ↗

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancerSemantic proximity Read ↗

Development and Validation of a General Clinical Model for Predicting Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer: Evidence from Meta-Analysis and Real-World StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.